Patients in the real world create a wealth of potential new data on their condition and response to treatment through their medical records and social communications that is currently inaccessible to new drug developers.
Goals and Objectives
With the 21st Century Cures Act in place and the potential for expanded access to new data resources, it becomes possible to more quickly identify potential drug safety issues and new uses for existing approved drugs.
- Secure, HIPAA-compliant clouds
- Predictive analytics
- Big data & analytics
Use Case Summary
Data from the broader patient population using approved drugs is much larger than the data collected during limited clinical trials. Insights from related drugs may provide key insights to better guide new drug development, take dangerous drugs off the market more quickly, and better understand how drugs work in the broader population.